Global Enteral Nutrition
Market size was valued at $5,661.6 million in 2017, and is projected to
reach $10,478.0 million in 2025, registering a CAGR of 7.9% from 2018 to 2025.
Enteral nutrition is the administration of food supplements using pumps and
tubes directly in the gastrointestinal tract of patients who cannot swallow
food or get enough nourishment by eating or drinking. These medical devices
deliver medications and nutrients directly into the stomach, duodenum, or
jejunum either via nose, mouth, or direct percutaneous route.
Increase in prevalence of several chronic
disorders such as cancer and neurological disorders worldwide, surge in
adoption of enteral nutrition over parenteral nutrition, rise in geriatric
population, and growth in malnutrition cases drive the market growth. However,
stringent governmental regulations and inadvertent dislodgment of tubes leading
to accidental disabilities and deaths impede the growth of the market.
Conversely, the development of newer products with minimal side effects and
presence of untapped market potential in the emerging economies are expected to
provide lucrative growth opportunities for the global enteral nutrition market.
Click Here
To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/5049
According to the WHO, the number of people
diagnosed with diabetes increased from 108 million in 1980 to 422 million in
2014. In addition, the prevalence rate of diabetes in adults over 18 years of
age increased from 4.7% in 1980 to 8.5% in 2014. This growth pattern is more
evident in middle- and low-income countries. Thus, growing prevalence of
diabetes fosters the growth of the enteral nutrition market.
As per the National Cancer Institute data,
it is estimated that 1,735,350 new cases of cancer are expected to be diagnosed
in the U.S. by the end of 2018. Moreover, according to the Centers for Disease
Control and Prevention (CDC) data, about half of all adults (approximately 117
million) worldwide suffered from one or more chronic health conditions in 2012,
while diabetes being the most common chronic disease. Therefore, burgeoning
number of cancer cases across the globe are expected to increase the adoption
of enteral feeding systems, thereby boosting the growth of the enteral
nutrition market.
Globally, the geriatric population who are
vulnerable to disorders such as cardiovascular, stroke, diabetes, gastric
diseases, and intestinal illnesses has increased tremendously in the last few
years. According to the data released by the U.S. Census Bureau, in 2015, about
617.1 million of the global population were in the age group of 65 years and
above. The number of elderly people is expected to increase by 60% in just 15
years and is projected to grow further in the subsequent two decades. Rapid
increase in geriatric population is one of the key drivers of the enteral
nutrition market, as they are highly susceptible to various diseases due to
decreased immunity and degeneration.
Enteral nutrition is preferred to parenteral
nutrition due to improvements in safety and ease of access. In addition, usage
of percutaneous jejunostomies, percutaneous dual tube gastrojejunostomies, and
nasojejunal tubes has become common with good safety records. Therefore, it is
highly acceptable as a home feeding therapy due to numerous advantages of
enteral feeding.
The emerging economies of the Asia-Pacific region offer lucrative growth
opportunities to the market players owing to improvement in healthcare
infrastructure and increase in demand for better healthcare services in the
region. Moreover, rise in prevalence of several chronic diseases in the
developing countries fuels the demand for enteral nutrition. Moreover, increase
in healthcare expenditure in these regions is projected to propel the enteral
nutrition market growth.
Digital marketing is now preferred to
conventional forms of advertising owing to the increased penetration of
internet and social media. Mobile apps and social media are set to play a
crucial role in assisting emerging markets, such as India, to catch up with the
technical superiority of peer countries such as China.
Indian pharmaceutical companies have begun
investing in the digital platform for marketing. In 2016, Sun Pharmaceuticals
Industries Ltd., an Indian multinational pharmaceutical company launched its
mobile app, RespiTrack, which has features such as medication reminders,
pre-programmed alerts, over-the-air review by the doctor and others.
GlaxoSmithKline plc, a British
pharmaceutical company equipped its employees with iPads to disseminate
real-time information on the developments in therapy areas. In addition, the
company used webinars, video chats, information portals, and platforms such as
Viva for doctors to push sales.
For
Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5049
Key Findings Of Enteral Nutrition
Market :
- The protein for diabetes care patient
segment by protein composition of enteral nutrition market is anticipated
to witness the fastest CAGR of 9.4% from 2018 to 2025.
- The standard protein diet segment by
protein composition dominated the global enteral nutrition market in 2017,
and it is anticipated to grow at a lucrative CAGR of 7.2% during the
forecast period.
- The online segment by distribution
channel is anticipated to witness the fastest CAGR of 9.0% in terms of
value during the forecast period.
- North America led the global enteral
nutrition market in terms of value in 2017 and is anticipated to witness a
CAGR of 7.1% during the forecast period.
- By form, the liquid segment dominated the
enteral nutrition market in 2017 and is anticipated to witness a
significant CAGR of 8.0% during the forecast period.
- The Asia-Pacific region is anticipated to
witness the fastest CAGR of 8.8% in terms of value during the forecast
period.
The major companies profiled in this report
are Abbott Laboratories, Nestl S.A., Danone SA, Fresenius Kabi AG, Mead Johnson
Nutrition Company, B. Braun Melsungen AG, Global Health Products, Inc., Meiji
Holdings Co., Ltd., Victus, Inc., and Hormel Foods Corporation.
No comments:
Post a Comment